Search
Patexia Community

Innovation, Technology, and IP News

Warner Defeated in a Trademark Opposition over Tweety Bird, Japan Patent Office (JPO) Dismisses the Action

Until 1997, Japan followed the examples of major industrialized countries regarding trademark law. They offered a pre-registration trademark opposition system, which allowed for filing ...

CNN Sued by FreePlay Music Over Alleged Copyright Infringement Facing a $17.4 Million Lawsuit

  Just last week, CNN made headlines by being in the center of them instead of being behind them as usual. The Rolling Stone magazine broke the news that the Cable News Network...

Fresh From the Bench: Latest Federal Circuit Court Case

CASE OF THE WEEK Treehouse Avatar LLC v. Valve Corp., Appeal No. 2022-1171 (Fed. Cir. Nov. 30, 2022) In the only precedential patent opinion issued by the Federal Circuit this week...

Female Entrepreneurs are Building Lifechanging Businesses. They Need Intellectual Property Protections to Do it.

As a woman who has spent her career as a serial entrepreneur and fighter for women entrepreneurs, I was appalled to read a recent letter from 100 members of Congress calling on Health...

Expert Testimony Inconsistent With Agreed-Upon Claim Construction Is Properly Stricken

Written by: Brianne M. Kingery & Jeremy Anapol TREEHOUSE AVATAR LLC v. VALVE CORPORATION Before Lourie, Reyna, and Stoll. Appeal from the U.S. District Court for the Western ...

Feed tagged as "biosimilars":
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought battle ... Read More »
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More »
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More »
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by providing... Read More »
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for emergency use by FDA... Read More »
Less than two months ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent... Read More »
AMGEN INC. v. HOSPIRA, INC. Before Moore, Bryson, and Chen.  Appeal from the United States District Court for the District of Delaware. Summary... Read More »
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s... Read More »
Written by Daniel A. Kamkar and Agnes Juang, Ph.D. Janssen Biotech Inc. and Celltrion Healthcare have taken the next step over Janssen’s blockbuster... Read More »
Written by Daniel K. Yarbrough, Ph.D. and Kerry S. Taylor, Ph.D. Bevacizumab (Avastin®) is the subject of the widely watched “patent dance”... Read More »
Written by Robert J. Hilton, Ph.D. and Jing Liu, Ph.D. On January 13, 2017, the Supreme Court granted certiorari in Amgen v. Sandoz, 794. f. 3d 1347 (Fed. Cir... Read More »
Biological pharmaceuticals are therapeutic drugs made from human or animal materials rather than chemicals, often indicated for immune system-related deficiencies... Read More »
The US Food and Drug Administration (FDA) today issued three draft guidance documents on biosimilar product development to assist industry in developing these... Read More »
  For swimmers looking to gain an edge on their competition, the notion that simply donning a high-tech swimsuit -- the surface of which was inspired by... Read More »
Yesterday, Samsung and Biogen announced that they have entered an agreement for the development, manufacturing, and marketing of biosimilars. Samsung Biologics was... Read More »
Menu